1.3. Analysis.
Comparison 1 3,4‐diaminopyridine treatment versus placebo, Outcome 3 Improvement in mean CMAP amplitude (assumed r = 0.5 for within‐patient treatment effects in cross‐over trials).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.